I became interested in Dr. Burzynski in 1993 after he treated my father for
a brain tumor, and ended up working for him from 1993 to 1998. Certainly,
not all of his patients were cured or even helped, but I saw first-hand many
patients with terminal diagnoses who recovered completely or partially,
particularly patients with brain tumors.
That's not just my observation. Dr. Burzynski's "best cases" of remission
have been confirmed by the chief of neuroradiology of the NCI way back in
1991 and by the chief of neuroradiology of Georgetown University more
recently. Such a series does not address the question of what percentage of
Burzynski's patients are helped, but it does prove the effectiveness of the
treatment in those patients whose scans were reviewed.
When I went to work for Dr. Burzynski I was naive enough to think that the
resistance to his treatment was all just a big misunderstanding. I still
don't claim to understand this very strange phenomenon completely, but I got
a glimpse of part of the reason when I got hold of the Director of New
Product Development for a large pharmaceutical company, and tried to
interest her in Dr. Burzynski's treatment. Her first question to me was,
what does it work best on? I told her I had seen the most impressive
results in brain tumors and non-hodgkins lymphoma. She snorted
sarcastically into the phone, "Hah! Those are real biggies!" implying of
course that there are not enough cases of those cancers to make it
economically worthwhile to pursue it. With that she hung up.